Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. 1993

C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
Infectious Diseases Unit, Hospital Doce de Octubre, Madrid, Spain.

The efficacy of ganciclovir, given prophylactically, to prevent cytomegalovirus-related disease was evaluated in liver transplant recipients, mostly seropositive, under treatment with OKT3 monoclonal antibodies. The incidence of cytomegalovirus disease and visceral involvement was reduced, respectively, from 52 and 36% in the control group to 12 and 8% in the ganciclovir-treated patients. Leukopenia was a frequent (32%) side effect of ganciclovir administration.

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
December 1995, Transplantation,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
January 2004, Transplantation proceedings,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
January 2003, Transplantation,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
January 1992, Transplantation,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
October 1995, Transplantation proceedings,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
December 1997, Transplantation,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
February 1991, Transplantation proceedings,
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
December 1992, Presse medicale (Paris, France : 1983),
C Lumbreras, and J R Otero, and J A Herrero, and R Gomez, and M Lizasoain, and J M Aguado, and F Colina, and I Garcia, and E Moreno, and A R Noriega
February 2010, Transplant infectious disease : an official journal of the Transplantation Society,
Copied contents to your clipboard!